Polymeric Nanomaterials for Probing and Modulating Innate Immune Responses
Polymeric Nanomaterials for Probing and Modulating Innate Immune Responses
批准号:
10657729
负责人:
Ashish A. Kulkarni
金额:
$39.88万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-01 至 2027-04-30
关键词:
AddressAffectBiologicalBiologyCaspaseCell CommunicationCellsCharacteristicsChronicDefense MechanismsDendritic CellsDevelopmentDiagnosticDiseaseEngineeringHomeostasisImmuneImmune TargetingImmune responseImmune systemImmunologyImmunotherapyIn VitroInflammasomeInflammationInflammatoryInflammatory ResponseInnate Immune ResponseInnate Immune SystemInvadedLibrariesMacrophageMonitorPolymersPropertyReportingResearchRoleSignal PathwaySiteStructureSurfaceSystemTestingTimeVisionchronic inflammatory diseasecytokinedesignengineering designimaging platformimaging probeimmunoengineeringimmunoregulationin vivomonocytenanomaterialsnanopolymernanoscienceneutrophilnext generationnovelpreventprogramsprotein complextool
中文摘要
摘要:
炎症是一种由先天免疫系统触发的防御机制,可抵御任何外来入侵
动态平衡,但当它持续几个月到几年的长时间时,它会转化为慢性
导致几种有害疾病的状况。炎性小体是一种已知的异源多聚体蛋白质复合体
用于激活炎症caspase,随后处理细胞因子,这使其成为
炎症期间的关键角色。炎性小体的异常激活可引发不良炎症
与慢性炎症性疾病进展相关的反应。几项研究已经调查了
纳米材料与免疫细胞的相互作用,以了解它们在各种生物应用中的作用并定制
以满足不同的需求。事实上,几种类型的纳米材料已经被广泛探索来靶向免疫
疾病部位的细胞来调节免疫反应。然而,我们最近的研究和最近的几个
报告表明,这些纳米材料中的许多都非特异性地激活免疫细胞中的炎症体,
有可能使疾病恶化。但对纳米材料免疫细胞的全面表征
导致炎症体激活和不需要的天然免疫反应的相互作用研究得很少。
由于缺乏适当的调查工具。我的研究计划的总体愿景是设计
免疫工程平台架起纳米科学和工程设计与免疫操纵之间的桥梁
解决免疫学中的基本问题和翻译问题的系统。我们专注于开发有效的
通过了解不同免疫系统组件之间的相互作用来制定免疫治疗策略,
各种纳米材料和免疫细胞之间的联系。具体地说,我们的目标是解决以下基本问题
炎症体生物学以及纳米材料的特性如何影响其与天然免疫细胞和
炎性小体激活。为了实现这一点,我们建议设计一个多参数聚合物的库
在单一系统中具有各种表面和核心特性的纳米材料平台。这将允许我们测试
这些纳米材料的特性对炎症体激活的影响,一次调整一种特性以
发展纳米材料的结构-性质-功能关系。我们已经开发出新型的高通量
成像平台,实现对炎症体激活的实时监测。我们还设计了一部小说
实时监测活体内炎性小体激活的成像探针。使用这些工具,在接下来的五年里,
我们的目标是了解纳米材料(基于聚合物)和免疫细胞(巨噬细胞,
单核细胞、树突状细胞和中性粒细胞)与炎性小体激活有关,并揭示
这种激活的体外和体内机制。总而言之,从这些研究中获得的信息可以
提供指导下一代纳米材料开发的设计标准,以控制、防止或
减轻炎症体信号通路,也提供了一个预测框架的调制
炎性小体激活在诊断和治疗中的潜在应用。
英文摘要
Abstract:
Inflammation is a defense mechanism triggered by innate immune system against any foreign invasion to restore
homeostasis, but when it sustains for a prolonged period of several months to years, it transforms into a chronic
condition resulting in several harmful diseases. The inflammasome is a hetero-multimeric protein complex known
for activating inflammatory caspases followed by subsequent processing of cytokines, which makes it one of the
key players during inflammation. Abnormal activation of inflammasomes can initiate undesirable inflammatory
responses associated with the progression of chronic inflammatory diseases. Several studies have investigated
nanomaterial interactions with immune cells to understand their role in various biological applications and tailor
them to different needs. Indeed, several types of nanomaterials have been widely explored to target the immune
cells at the disease site to modulate the immune responses. However, our recent studies and several recent
reports suggest that many of these nanomaterials activate inflammasomes in immune cells non-specifically,
potentially exacerbating the disease. But the comprehensive characterization of the nanomaterial-immune cell
interactions that results in inflammasome activation and the unwanted innate immune response is poorly studied
due to a lack of appropriate investigative tools. The overall vision of my research program is to design
immunoengineering platforms bridging nanoscience and engineering design with manipulation of the immune
system to address fundamental and translational questions in immunology. We focus on developing effective
immunotherapy strategies by understanding the interactions between different immune system components,
between various nanomaterials and immune cells. Specifically, we aim to address fundamental questions in
inflammasome biology and how nanomaterial properties affect their interactions with innate immune cells and
inflammasome activation. To accomplish this, we propose to engineer a library of multiparametric polymeric
nanomaterial platform with various surface and core characteristics in a single system. This will allow us to test
the effect of these nanomaterial properties on inflammasome activation, tweaking one property at a time to
develop nanomaterial structure-property-function relationships. We have developed novel high-throughput
imaging platform to enable monitoring of inflammasome activation in real time. We have also engineered novel
imaging probes to monitor inflammasome activation in vivo in real time. Using these tools, over next five years,
we aim to understand the interactions between nanomaterials (polymer-based) and immune cells (macrophages,
monocytes, dendritic cells and neutrophils) in the context of inflammasome activation and uncover the
mechanisms of this activation in vitro and in vivo. In summary, the information obtained from these studies could
provide design criteria that guide the development of next-generation of nanomaterials to control, prevent or
mitigate inflammasome signaling pathways and also provide a predictive framework for modulation of the
inflammasome activation for potential applications in diagnostics and therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金